Principal Investigator, Kathleen Schmainda, PhD, MCW professor of Biophysics, will leverage her foundational work in perfusion MRI technologies to more precisely identify brain tumor burden and provide earlier treatment response assessment over what is currently available. The grant’s objectives also include incorporating artificial intelligence capabilities for streamlined and automated processing.
